🔗 Share this article

Given that the United States continues making unprecedented adjustments to its vaccination recommendations, an unexpected name appears somewhat surprisingly: Dr. Tracy Beth Høeg, an American of Danish descent sports physician and public health researcher who rose to prominence by expressing skepticism about coronavirus vaccinations during the global health crisis and has concentrated on potential deaths following COVID-19 vaccination in her brief tenure at the FDA.

Scheduled Shifts to Pediatric Immunization Schedule

Agency leaders had intended to unveil radical changes to the pediatric vaccination calendar recently, aligning the US with the Danish national calendar, according to reports – a substantial departure that would put the US at odds with a large portion of the global community with little proof for public health gain. The announcement has been postponed until the new year.

In place of the top vaccines chief, Tracy Beth Høeg is set to speak at the gathering. She was newly appointed acting director of the FDA’s CDER, the fifth person to lead the center this year.

Consolidating Power at the FDA

Høeg's temporary position may indicate a strengthened alliance between the pharmaceutical and biologics centers as Høeg and Dr. Prasad solidify control at the FDA – and it points to a greater focus upon dismantling already-approved immunizations at the FDA.

Høeg has repeatedly called for halting certain pediatric shot schedules in the US so as to align more like Denmark, a nation with nationalized medicine and a number of inhabitants about the population of Wisconsin’s.

So far statements, she has kept her attention on immunizations – traditionally the domain of Prasad, director of the FDA’s CBER – instead of drug regulation.

Concerns Over Expertise

The appointee has little discernible track record in pharmaceutical research, regulation or leadership, which has been typical for former leaders of the biologics center. She has worked at the FDA as a top consultant to the commissioner and the vaccine center since earlier this year.

“She doesn’t seem to have any of the qualifications” for running the drug-regulation department, stated a neurologist and psychiatrist. “She’s never run a clinical trial. She has no expertise in leading a large organization. She has no expertise in drug approvals.”

Former heads of CBER would “understand regulatory frameworks and the research of drug development”, noted a former acting FDA commissioner. “Clearly, she doesn’t have the type of experience that previous people who led CBER have had.”

The drug center has an vast range of responsibilities at the agency, the former commissioner emphasized.

“Everybody just focuses on the novel medication approvals, but the off-patent medication office approves thousands of generic drugs. There’s a biosimilars division, non-prescription drug unit and more, and all of those need to be managed,” Woodcock said. “The responsibility you overlook, that is precisely what that I always told people is going to cause problems.”

Additionally, a major leadership element to the job, which oversees in excess of 5,000 employees. “It is a enormous management job, if you perform it correctly,” the former official concluded.

Official Statement and Contentious Programs

In response to concerns about Høeg’s fitness for the role and whether this selection indicates greater collaboration among agency officials on immunizations, a spokesperson stated that the “questions stem from flawed premises”.

“Her resume aligns with the duties of her position,” the official explained, pointing to the time Dr. Høeg spent counseling the FDA commissioner on “pharmaceutical safety and approval science, including computational safety modeling and shot safety tracking”.

As the temporary head, Høeg assumes responsibility for the agency head's controversial expedited review system, a controversial rapid therapy clearance system that reportedly worried her preceding directors. “By what process are these medications being selected for this voucher program? Who takes the decisions?” Howard asked. “There is a lot of lack of transparency happening at the regulatory body right now.”

Overall, he remarked, “the Food and Drug Administration appears to be shifting towards more relaxed regulations of pharmaceuticals, aside from immunizations.”

Documented History on Vaccines

Regarding immunizations, Høeg has a more established, if problematic, track record, Howard have noted. She published a research paper using unverified crowd-sourced reports to assess the rate of myocarditis after COVID-19 immunization. She consulted for the state of Florida chief medical officer Joseph Ladapo, who allegedly have changed statistics to imply Covid vaccines are pose a greater threat than they are.

Included in her “wish list” for the new administration encompassed altering rules for new vaccines and discontinuing “optional” vaccines, she said following the vote on a online show. At the FDA, Høeg has reportedly proposed preventing teenage boys from receiving COVID-19 vaccinations.

“She is an all-around dogmatist who begins with her preconceived notions and reverse-engineers to fit the evidence in a highly disingenuous, untruthful fashion,” Dr. Howard argued.

Gaining Influence and a “Revenge Tour”

Dr. Høeg became part of fellow skeptics, {like|